COHR COHERENT CORP.
Optical Instruments & Lenses · NYSE · SEC CIK 820318 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY30.8%
TTM net income YoY285.6%
TTM EPS YoY580.3%
Revenue 3-yr CAGR17.5%
Net income 3-yr CAGR—
Margins
Gross margin38.2%
Operating margin—
Net margin12.2%
FCF margin-23.2%
EBITDA margin—
Returns
ROE11.2%
ROA5.5%
ROIC (approx.)—
Asset turnover0.45x
Leverage & solvency
Liabilities / assets42.4%
Debt / equity0.35x
Current ratio2.29x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.06x
Accruals ratio5.9%
Payout ratio—
Capex / revenue22.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $7.12B | $5.81B | $4.71B | $5.16B | $3.32B |
| Cost of revenue | $4.45B | $3.77B | $3.25B | $3.54B | $2.05B |
| Gross profit | $2.67B | $2.04B | $1.46B | $1.62B | $1.27B |
| R&D expense | $722.95M | $581.92M | $478.79M | $499.60M | $377.11M |
| SG&A expense | $1.04B | $926.45M | $854.00M | $1.04B | $474.10M |
| Operating income | — | — | $96.12M | -$37.12M | $414.29M |
| Interest expense | — | — | — | $286.87M | $121.25M |
| Pretax income | $847.73M | $94.18M | -$147.65M | -$355.56M | $281.81M |
| Income tax | $60.85M | $64.12M | $11.12M | -$96.10M | $47.05M |
| Net income | $805.00M | $49.36M | -$156.15M | -$259.46M | $234.76M |
| EBITDA | — | — | $655.88M | $681.65B | $701.07M |
| EPS (basic) | 4.34 | -0.52 | -1.84 | -2.93 | 1.57 |
| EPS (diluted) | 4.12 | -0.52 | -1.84 | -2.93 | 1.45 |
| Weighted avg. shares (diluted) | 195.39M | 154.75M | 151.64M | 137.58M | 116.51M |
| Balance sheet | |||||
| Cash & equivalents | $1.16B | $1.63B | $1.79B | $837.57M | $2.58B |
| Short-term investments | $825.00M | $0 | — | — | — |
| Receivables | $1.34B | $964.05M | $848.54M | $901.53M | $700.33M |
| Inventory | $2.58B | $1.44B | $1.29B | $1.27B | $902.56M |
| Current assets | $6.93B | $3.93B | $3.66B | $3.25B | $4.31B |
| PP&E, net | $3.00B | $1.88B | $1.82B | $1.78B | $1.36B |
| Goodwill | $4.38B | $4.47B | $4.46B | $4.51B | $1.29B |
| Intangibles | $2.88B | $3.20B | $3.50B | $3.81B | $635.40M |
| Total assets | $18.30B | $14.91B | $14.49B | $13.71B | $7.84B |
| Current liabilities | $2.85B | $1.79B | $1.34B | $1.08B | $1.27B |
| Short-term debt | $7.92M | $188.31M | $73.77M | $74.84M | $403.21M |
| Long-term debt | $3.21B | $3.50B | $4.03B | $4.23B | $1.90B |
| Total debt | $3.22B | $3.69B | $4.10B | $4.31B | $2.30B |
| Total liabilities | $7.06B | $6.43B | $6.54B | $6.48B | $3.46B |
| Shareholders' equity | $10.90B | $5.64B | $5.21B | $4.99B | $3.62B |
| Net debt | $2.06B | $2.05B | $2.31B | $3.47B | -$281.94M |
| Cash flow statement | |||||
| Operating cash flow | $79.51M | $633.60M | $545.73M | $634.02M | $413.33M |
| Capital expenditure | $1.10B | $440.84M | $346.82M | $436.06M | $314.33M |
| Free cash flow | -$1.02B | $192.76M | $198.91M | $197.97M | $99.00M |
| Investing cash flow | -$1.41B | -$414.21M | -$350.71M | -$5.93B | -$320.08M |
| Financing cash flow | $1.48B | -$451.73M | $758.27M | $3.55B | $862.95M |
| Depreciation & amortization | $521.89M | $553.60M | $559.76M | $681.69B | $286.78M |
| Stock-based compensation | $186.47M | $160.24M | $126.05M | $148.87M | $73.21M |
| Share buybacks | — | — | — | — | $0 |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.